Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Georgiamune sells solid tumor drug to Italy's Menarini for up to $1.1B

A small Maryland biotech is shipping a preclinical cancer drug to a family-owned Italian pharma in a deal worth up to $1.1 billion if all goes according to plan, the companies exclusively told Endpoints News. ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 22 October →